Aardvark Therapeutics, Inc. · NASDAQ:AARD
Aardvark Therapeutics, Inc. shareholders
As of Sep 30, 2026, 74 institutions reported holding Aardvark Therapeutics, Inc., 43.6% of its shares. Largest: Decheng Capital LLC, Laurion Capital Management LP and Citadel. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aardvark Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Decheng Capital LLC | 3.92M | 17.9% | no change | Nov 13, 2026 |
| Laurion Capital Management LP | 1.03M | 4.7% | no change | Oct 30, 2026 |
| Citadel | 975K | 4.5% | −308K | Nov 16, 2026 |
| EcoR1 Capital, LLC | 720K | 3.3% | +324K | Nov 16, 2026 |
| Vanguard | 639K | 2.9% | −4,951 | Nov 13, 2026 |
| ExodusPoint Capital Management, LP | 316K | 1.4% | new | Nov 16, 2026 |
| BlackRock | 195K | 0.89% | +7,575 | Nov 13, 2026 |
| Geode Capital | 139K | 0.63% | −10,837 | Nov 6, 2026 |
| Marshall Wace, LLP | 132K | 0.60% | +113K | Nov 13, 2026 |
| Jacobs Levy Equity Management, Inc | 130K | 0.59% | new | Nov 16, 2026 |